IP 1000 mg Metformin Hydrochloride Sustained Release
Jun 22, 2023
Metformin Hydrochloride Sustained Release IP 1000 mg
SEIZMET SR 1000
Metformin hydrochloride is a medication commonly used to treat type 2 diabetes. It is available in various formulations, including immediate-release and sustained-release formulations. The term "IP" refers to Indian Pharmacopoeia, which is a set of standards and guidelines for pharmaceuticals in India.
Metformin hydrochloride sustained-release IP 1000 mg refers to a specific formulation of metformin hydrochloride in which each tablet contains 1000 mg of the active ingredient. Sustained-release formulations are designed to release the medication slowly over an extended period, providing a steady and prolonged effect.
STERIS PHARMA Generic medicines are typically much cheaper than brand-name drugs. Generic medicines have the same active ingredients, strength, dosage form, and route of administration as their brand-name counterparts.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/seizmet-sr-1000-134083
Recent Post
Gabapentin 450 mg Sustained Release: Uses in Neuropathy and Seizure Disorders
What Is Glycopyrrolate, Formoterol & Budesonide Inhaler? Complete Guide for COPD Patients
Why Doctors Recommend Bacillus Clausii Spores Suspension for Gut Health
How Brimonidine Tartrate Eye Drops IP 0.2% w/v Help Lower Intraocular Pressure
Dorzolamide and Timolol Eye Drops IP: Effective Treatment for Glaucoma and Ocular Hypertension
Bethanechol Chloride Extended Release 75 mg Tablets: Uses, Dosage, and Side Effects
How Metoprolol 25 mg & Amlodipine 2.5 mg Tablets Help Control Hypertension
Lactitol Monohydrate Syrup 66.67% w/v: Uses, Benefits, Dosage & Side Effects Explained
Why Doctors Recommend Nebivolol Hydrochloride and Cilnidipine Tablets for Hypertension
How Risedronate Sodium 35 mg Helps Strengthen Bones And Prevent Fractures ?